(BLUEBIRD BIO INC)

	BLUE latest price $78.9500 (9.42%) ($71.3100 - $79.7000) on Tue. Dec. 6, 2016.
	Trend Analysis and Forecast
Average Daily Percentage Swing	5.41% (three month average)
RSI	66
Latest Price	$78.9500(9.42%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	BLUE advances 4.3% a day on average for past five trading days.
Weekly Trend	BLUE advances 7% a week on average for past two weeks.
Market Behavior	Value stock rally for large cap. Broad based rally for small cap.
Correlated ETFs	Broad market will support BLUE advance at 0% a week (0% probability)   XBI(59%)    IBB(54%)    ARKG(51%)    ARKK(47%)    IWO(45%)
Factors Impacting BLUE price	BLUE will decline at least -2.705% in a week (0% probabilities).   VIXM(-17%)    UUP(-10%)    TLT(-10%)    SHY(-6%)    IPO(-3%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-2.705% (StdDev 5.41%)
Hourly BBV	0 ()
Intraday Trend	9.7%

5 Day Moving Average	$69.97(12.83%)
10 Day Moving Average	$66.54(18.65%)
20 Day Moving Average	$62.6(26.12%)
To recent high	0%
To recent low	91.2%
Market Cap	$5.226b

bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. Its integrated product platform includes gene therapy, cancer immunotherapy, and gene editing. Its product pipeline includes Lenti-D, LentiGlobin, BCL11a shRNA, bb2121, and bb21217. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Cambridge, MA.

Analysis   News   Options   Weekly Chart   Daily Chart   2 Month Daily Chart   

  >  20170106